{"id":"tritanrix-hepb-hiberix-kft","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site pain"},{"rate":"5-10%","effect":"Fever"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by stimulating the body's immune system to produce antibodies against these pathogens, providing long-term immunity. The vaccine contains inactivated or attenuated forms of the pathogens, which are unable to cause disease but can still trigger an immune response. This immune response helps the body to recognize and fight off future infections.","oneSentence":"Tritanrix-HepB/Hiberix Kft. is a vaccine that protects against diphtheria, tetanus, pertussis, hepatitis B, and Hib infections.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:12.201Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Protection against diphtheria, tetanus, pertussis, hepatitis B, and Hib infections in infants and children."},{"name":"Prevention of invasive Hib disease, including meningitis and sepsis, in children under 5 years old."}]},"trialDetails":[{"nctId":"NCT00169442","phase":"PHASE3","title":"Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-02-10","conditions":"Whole Cell Pertussis, Diphtheria, Hepatitis B","enrollment":745},{"nctId":"NCT00473668","phase":"PHASE3","title":"Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-06-01","conditions":"Whole Cell Pertussis, Haemophilus Influenzae Type b, Tetanus","enrollment":300},{"nctId":"NCT00332566","phase":"PHASE3","title":"Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-06","conditions":"Hepatitis B, Whole Cell Pertussis, Tetanus","enrollment":148}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DTPw-HBV/Hib Kft"],"phase":"phase_3","status":"active","brandName":"Tritanrix™-HepB/Hiberix™ Kft.","genericName":"Tritanrix™-HepB/Hiberix™ Kft.","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"Tritanrix-HepB/Hiberix Kft. is a vaccine that protects against diphtheria, tetanus, pertussis, hepatitis B, and Hib infections. Used for Protection against diphtheria, tetanus, pertussis, hepatitis B, and Hib infections in infants and children., Prevention of invasive Hib disease, including meningitis and sepsis, in children under 5 years old..","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}